DexCom Change in Assets/Liabilities 2010-2025 | DXCM

DexCom change in assets/liabilities for the twelve months ending June 30, 2025 was $-0.025B, a 147.06% increase year-over-year.

  • DexCom annual change in assets/liabilities for 2024 was $-0.02B, a 266.39% decline from 2023.
  • DexCom annual change in assets/liabilities for 2023 was $0.012B, a 109.66% decline from 2022.
  • DexCom annual change in assets/liabilities for 2022 was $-0.126B, a 894.49% increase from 2021.

DexCom Change in Assets/Liabilities 2010-2025 | DXCM

  • DexCom annual change in assets/liabilities for 2024 was $-0.02B, a 266.39% decline from 2023.
  • DexCom annual change in assets/liabilities for 2023 was $0.012B, a 109.66% decline from 2022.
  • DexCom annual change in assets/liabilities for 2022 was $-0.126B, a 894.49% increase from 2021.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$182.7B
Intuitive Surgical (ISRG)$168.4B
IDEXX Laboratories (IDXX)$50.6B
Edwards Lifesciences (EW)$47.6B
Alcon (ALC)$39.1B
IQVIA Holdings (IQV)$31.5B
Mettler-Toledo (MTD)$26.3B
STERIS (STE)$24.4B
Waters (WAT)$17.3B
SONOVA HOLDING (SONVY)$17B
Hologic (HOLX)$14.9B
Penumbra (PEN)$9.8B
Sysmex ADR (SSMXY)$8.3B
Globus Medical (GMED)$8.2B
Masimo (MASI)$7.8B
Teleflex (TFX)$5.5B
Glaukos (GKOS)$5.1B
TransMedics (TMDX)$4.1B
Integer Holdings (ITGR)$3.7B
LivaNova (LIVN)$2.9B
Alphatec Holdings (ATEC)$2.4B
Veracyte (VCYT)$2.3B
PROCEPT BioRobotics (PRCT)$2.2B
Artivion (AORT)$2B
Nihon Kohden (NHNKY)$1.9B
Elekta AB (EKTAY)$1.9B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Pulse Biosciences (PLSE)$1.1B
Integra LifeSciences Holdings (IART)$1.1B